reported that TRIM21 expression in colitis-associated colorectal cancer (CAC) decreased and was negatively associated with colon cancer occurrence, further suggesting an anti-cancer effect of TRIM21 (88). This evidence concerns the gene TRIM21 and colonic neoplasm.